JD Health International Inc. (JDHIF)

3.0300 0.0000 (0.00%) At close: 09:33AM EDT

JD Health International Inc.

Jingdong Headquarters
Block C, Building 2 No. 20 Kechuang 11 Street, Daxing Dist. Yizhuang Eco. and Tech Development Zone
Beijing 101111
China

https://ir.jdhealth.com

Sector(s): Healthcare
Industry: Medical Care Facilities
Full-time employees: 3,118

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Enlin Jin	CEO & Executive Director	264.41k	N/A	1981
Ms. Deng Hui	Chief Financial Officer	N/A	N/A	1987
Mr. Ming King Chiu FCIS, FCS	Company Secretary	N/A	N/A	1977

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China and internationally. It offers pharmaceutical and healthcare products, including OTC drugs, prescription drugs, and medical devices and supplies, as well as health supplements and tonics through direct selling and an online retail pharmacy network. The company also provides online medical consultation, consumer healthcare, and health management services; hospital or doctor referral, health check-ups, genetic testing, and beauty care services; and intelligent healthcare solutions, as well as technical and advertising services. In addition, it is involved in order management, client management, and other merchants operational and maintenance support activities. The company was incorporated in 2018 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. operates as a subsidiary of JD Jiankang Limited.

Corporate governance

JD Health International Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.